Webinar – Opportunities and challenges for pharma and biotech companies in 2021 - Speaker biographies
Ben Ashwell, editor, IR Magazine and Corporate Secretary
Ben Ashwell is the editor at IR Magazine and Corporate Secretary, covering investor relations, governance, risk and compliance. Prior to this, he was the founder and editor of Executive Talent, the global quarterly magazine from the Association of Executive Search and Leadership Consultants. Before moving to the US, Ben was the vice president and editor at Executive Grapevine, overseeing a daily news website, ten annual supplements and HR Grapevine, the UK’s leading HR and talent management magazine. In his spare time, Ben writes fiction, poetry and arts and culture reviews. Eyewear Publishing recently named him in their list of the Best New British and Irish Poets.
Annie Chang, head of investor relations, Sutro Biopharma
Annie Chang is the Head of Investor Relations at Sutro Biopharma. She has over 15 years of experience in various strategic corporate and advisory roles. Prior to Sutro, she was at Solebury Trout, where she was a Vice President of Investor Relations and led the investor relations and communications programs for various companies in the biotechnology space. She previously worked in Corporate Development roles at technology companies including Yahoo and NIO, was the Director of Research at Icefield Capital, and was an Investment Banking Analyst at Morgan Stanley and J.P. Morgan. Ms. Chang has a B.S. in Finance from New York University and an MBA from INSEAD.
Nick Mazing, head of research, Sentieo
Nick Mazing is Director of Research for Sentieo, a financial and corporate research platform for executives, investment analysts, and researchers. His career also includes having worked on both the buy side and on the sell side at Lehman Brothers. He holds an MBA from Columbia Business School and is based in Sentieo’s New York City office.